Atlas Trials

Antihypertensive Effect of Different Doses of Rostafuroxin in Comparison With Losartan

Clinical trial NCT03217825 · COMPLETED

Trial details

NCT number
NCT03217825
Sponsor
Windtree Therapeutics
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypertension
Start date
2015-12-01
Primary completion
2018-02-08
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.